PT819002E - Utilizacao de derivados de imidazol¬1,2-a|piridina-3-acetamida para o tratamento terapeutico de sindromas neuro-psiquiatricos associados com a disfuncao dos circuitos neurais dos ganglios basais - Google Patents

Utilizacao de derivados de imidazol¬1,2-a|piridina-3-acetamida para o tratamento terapeutico de sindromas neuro-psiquiatricos associados com a disfuncao dos circuitos neurais dos ganglios basais

Info

Publication number
PT819002E
PT819002E PT96907656T PT96907656T PT819002E PT 819002 E PT819002 E PT 819002E PT 96907656 T PT96907656 T PT 96907656T PT 96907656 T PT96907656 T PT 96907656T PT 819002 E PT819002 E PT 819002E
Authority
PT
Portugal
Prior art keywords
ganglios
imidazolic
neuro
basal
pyridine
Prior art date
Application number
PT96907656T
Other languages
English (en)
Inventor
Elena Benincasa
Original Assignee
Clarendon Trading & Investimen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarendon Trading & Investimen filed Critical Clarendon Trading & Investimen
Publication of PT819002E publication Critical patent/PT819002E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT96907656T 1995-04-07 1996-04-02 Utilizacao de derivados de imidazol¬1,2-a|piridina-3-acetamida para o tratamento terapeutico de sindromas neuro-psiquiatricos associados com a disfuncao dos circuitos neurais dos ganglios basais PT819002E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000223A IT1276522B1 (it) 1995-04-07 1995-04-07 Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei

Publications (1)

Publication Number Publication Date
PT819002E true PT819002E (pt) 2003-01-31

Family

ID=11403250

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96907656T PT819002E (pt) 1995-04-07 1996-04-02 Utilizacao de derivados de imidazol¬1,2-a|piridina-3-acetamida para o tratamento terapeutico de sindromas neuro-psiquiatricos associados com a disfuncao dos circuitos neurais dos ganglios basais

Country Status (25)

Country Link
US (1) US5891891A (pt)
EP (1) EP0819002B1 (pt)
JP (1) JP4049390B2 (pt)
KR (1) KR100425628B1 (pt)
CN (1) CN1198612C (pt)
AR (1) AR003414A1 (pt)
AT (1) ATE222763T1 (pt)
AU (1) AU707759B2 (pt)
CA (1) CA2217590C (pt)
CZ (1) CZ292020B6 (pt)
DE (1) DE69623271T2 (pt)
DK (1) DK0819002T3 (pt)
EA (1) EA000396B1 (pt)
ES (1) ES2182967T3 (pt)
HU (1) HUP9900733A3 (pt)
IL (1) IL117824A (pt)
IT (1) IT1276522B1 (pt)
MX (1) MX9707712A (pt)
NO (1) NO315408B1 (pt)
NZ (1) NZ304107A (pt)
PL (1) PL322647A1 (pt)
PT (1) PT819002E (pt)
TW (1) TW450816B (pt)
WO (1) WO1996031210A1 (pt)
ZA (1) ZA962711B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6333345B1 (en) 1999-05-14 2001-12-25 Sepracor, Inc. Methods of using and compositions comprising N-desmethylzolpidem
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
WO2001078725A2 (en) * 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
DE60125429T2 (de) * 2000-04-24 2007-09-27 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrat solvat
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10117183A1 (de) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
GB0311457D0 (en) * 2003-05-19 2003-06-25 Sciencom Ltd New therapeutic use
EP1624867A1 (en) * 2003-05-19 2006-02-15 Sciencom Ltd Further therapeutic use of zolpidem
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DK1691811T3 (da) 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
ES2337700T3 (es) 2004-02-18 2010-04-28 Sepracor, Inc. Terapia combinada de agonista de dopamina con sedantes para mejorar la calidad del sueño.
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
CA2629740A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
GB2443928A (en) * 2006-11-08 2008-05-21 Regen Therapeutics Plc Transdermal pharmaceutical composition comprising Zolpidem
GB0809936D0 (en) * 2008-05-30 2008-07-09 Regen Therapeutics Plc Therapeutic use of zolpidem
WO2017214442A1 (en) 2016-06-08 2017-12-14 President And Fellows Of Harvard College Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
WO2019232046A1 (en) 2018-05-29 2019-12-05 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
WO2020198275A1 (en) 2019-03-25 2020-10-01 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US5032595A (en) * 1989-11-24 1991-07-16 Fidia-Georgetown Institute For The Neurosciences Method of stimulating steroidogenesis with alpidem
US5206382A (en) * 1991-06-27 1993-04-27 Fidia Georgetown Institute For The Neurosciences Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders

Also Published As

Publication number Publication date
KR19980703707A (ko) 1998-12-05
NO315408B1 (no) 2003-09-01
IL117824A0 (en) 1996-08-04
ITRM950223A0 (it) 1995-04-07
EP0819002A1 (en) 1998-01-21
AR003414A1 (es) 1998-08-05
ATE222763T1 (de) 2002-09-15
NZ304107A (en) 2000-12-22
HUP9900733A2 (hu) 1999-07-28
HUP9900733A3 (en) 2003-05-28
TW450816B (en) 2001-08-21
JP4049390B2 (ja) 2008-02-20
DK0819002T3 (da) 2003-01-06
NO974603L (no) 1997-11-24
DE69623271T2 (de) 2003-07-24
MX9707712A (es) 1998-03-31
CZ292020B6 (cs) 2003-07-16
DE69623271D1 (de) 2002-10-02
EP0819002B1 (en) 2002-08-28
KR100425628B1 (ko) 2004-06-23
NO974603D0 (no) 1997-10-06
PL322647A1 (en) 1998-02-16
CA2217590A1 (en) 1996-10-10
CZ316797A3 (cs) 1998-05-13
CN1183719A (zh) 1998-06-03
CA2217590C (en) 2008-08-12
AU5120096A (en) 1996-10-23
AU707759B2 (en) 1999-07-22
IL117824A (en) 2000-08-31
IT1276522B1 (it) 1997-10-31
EA000396B1 (ru) 1999-06-24
ITRM950223A1 (it) 1996-10-07
JPH11503149A (ja) 1999-03-23
ZA962711B (en) 1996-07-30
WO1996031210A1 (en) 1996-10-10
US5891891A (en) 1999-04-06
CN1198612C (zh) 2005-04-27
EA199700308A1 (ru) 1998-04-30
ES2182967T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
PT819002E (pt) Utilizacao de derivados de imidazol¬1,2-a|piridina-3-acetamida para o tratamento terapeutico de sindromas neuro-psiquiatricos associados com a disfuncao dos circuitos neurais dos ganglios basais
NO305886B1 (no) Anvendelse av et organisk nitritt for fremstilling av medikamenter for kontinuerlig, vasodilatorisk terapi
IS4570A (is) Imidazó[1,2-a]pýridín afleiður
EE04280B1 (et) Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
NO975661D0 (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
DE69430699D1 (de) Medikamente abgebende stents
NO975662D0 (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
PT1105390E (pt) Derivados de imidazo¬1,2-a|piridina para o tratamento de doencas gastrointestinais
EE9700168A (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
PT879051E (pt) Administracao transdermica de risperidona com velocidade controlada
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
ITRM950484A0 (it) Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla gastrica e quindi gastroprotettivo.
NO944809L (no) Biologisk aktive ureidoderivater som er nyttig i behandling av lentivirus-indusert sykdom
FR2699920B1 (fr) Dérivés d'imidazo [2,1-b] benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique.
FR2741073B1 (fr) Derives de 4,5-dihydroimidazo(1,2-a)pyrrolo(1,2,3-cd) benzimidazole, leur preparation et leur application en therapeutique
NO974651D0 (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
FR2700546B1 (fr) Dérivés d'imidazo[2,1-b]benzoxazole-3-acétamide, leur préparation et leur application en thérapeutique.
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
FR2697253B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2694702B3 (fr) Bracelet therapeutique perfectionne.
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
FI882383A (fi) Derivat av 3-metylacylamino-5,6,7,8 -tetrahydroimidazo/1,2-a/-pyridin, deras framstaellning och anvaendning i terapi.
MX9200555A (es) Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil.
ITRM930412A0 (it) Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.